Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 41Breast Neoplasms 40Lung Neoplasms 25Carcinoma, Non-Small-Cell Lung 20Colorectal Neoplasms 19Uterine Cervical Neoplasms 13Prostatic Neoplasms 13Head and Neck Neoplasms 11Carcinoma, Hepatocellular 11Pancreatic Neoplasms 10Melanoma 10Ovarian Neoplasms 9Neoplastic Cells, Circulating 7Myelodysplastic Syndromes 7Glioma 7Esophageal Neoplasms 7Endometrial Neoplasms 7Brain Neoplasms 7Sarcoma 6Multiple Myeloma 6Gastrointestinal Neoplasms 6Carcinoma, Renal Cell 6Triple Negative Breast Neoplasms 5Neoplasm Metastasis 5Leukemia, Myeloid, Acute 5Disease 5Colonic Neoplasms 5Uveal Melanoma 4Skin Neoplasms 4Neoplasm, Residual 4

Interventions

vedolizumab 1Surveys and Questionnaires 1Photopheresis 1Phlebotomy 1Mycophenolic Acid 1Methoxsalen 1Infliximab 1Blood Specimen Collection 1Azathioprine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hepatitis × Blood Specimen Collection × 1 year × Clear all
NCT02908048 2026-05-05

Extracellular RNA Markers of Liver Disease and Cancer

Mayo Clinic

Terminated
1,865 enrolled
Gastrointestinal

Bile Duct Neoplasms, Biliary Tract Neoplasms, Fibrosis, Hepatitis, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡